NTNX Form 144: Insider plans to sell 144,707 shares on 10/02/2025
Rhea-AI Filing Summary
Nutanix, Inc. reported a proposed sale of 144,707 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $11,059,204.05. The filing lists the approximate sale date as 10/02/2025 on NASDAQ. The shares to be sold were acquired from multiple compensation events: performance shares granted on 03/15/2024 (14,346 shares) and 09/15/2024 (89,394 shares), restricted stock grants on 03/15/2024 (25,159 shares) and 09/15/2025 (2,318 shares), an employee purchase on 03/20/2024 (741 shares) paid in cash, and additional performance shares on 09/15/2025 (12,749 shares). The filing states no securities were sold by the person in the prior three months and includes the standard representation about no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider intends to sell 144,707 shares (~0.054% of outstanding shares) via Morgan Stanley on 10/02/2025.
The Form 144 discloses a planned sale of 144,707 Nutanix common shares with an aggregate market value of $11,059,204.05. The shares originate from recent compensation awards and an employee purchase, indicating the source is company grants rather than open-market purchases.
This filing is a regulatory disclosure of a proposed insider sale rather than an executed transaction; it notifies investors of potential forthcoming supply but does not itself confirm trade execution or motive.